Format

Send to

Choose Destination
Cleve Clin J Med. 2018 May;85(5):399-411. doi: 10.3949/ccjm.85a.17076.

Hypertrophic cardiomyopathy: A complex disease.

Author information

1
Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH, USA.
2
Department of Cardiothoracic Surgery, Heart and Vascular Institute, and Transplantation Center, Cleveland Clinic, Cleveland, OH, USA.
3
Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA.
4
Clinical Instructor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA.
5
Clinical Assistant Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA.
6
Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Heart and Vascular Institute, and Department of Diagnostic Radiology, Cleveland Clinic, Cleveland, OH, USA. desaim2@ccf.org.

Abstract

Hypertrophic cardiomyopathy (HCM) is a complex cardiovascular disease with wide phenotypic variations. Despite significant advances in imaging and genetic testing, more information is needed about the roles and implications of these resources in clinical practice. Patients with suspected or established HCM should be evaluated at an expert referral center to allow for the best multidisciplinary care. Research is needed to better predict the risk of sudden cardiac death in those judged to be at low risk by current risk-stratification methods.

PMID:
29733784
DOI:
10.3949/ccjm.85a.17076
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center